140 related articles for article (PubMed ID: 18171331)
21. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
22. Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
Geng Y; Wu CG; Bhattacharyya SP; Tan D; Guo ZP; Yu MY
Transfusion; 2007 May; 47(5):883-9. PubMed ID: 17465954
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
24. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
Rinckel LA; Buno BR; Gierman TM; Lee DC
Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
[TBL] [Abstract][Full Text] [Related]
25. [Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives].
Servant-Delmas A; Mercier M; Laperche S; Lefrère JJ
Transfus Clin Biol; 2009; 16(5-6):482-8. PubMed ID: 19880339
[TBL] [Abstract][Full Text] [Related]
26. Quantitative real-time detection of parvovirus B19 DNA in plasma.
Koppelman MH; Cuypers HT; Emrich T; Zaaijer HL
Transfusion; 2004 Jan; 44(1):97-103. PubMed ID: 14692974
[TBL] [Abstract][Full Text] [Related]
27. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.
Saldanha J; Lelie N; Yu MW; Heath A;
Vox Sang; 2002 Jan; 82(1):24-31. PubMed ID: 11856464
[TBL] [Abstract][Full Text] [Related]
28. Update of the human parvovirus B19 biology.
Servant-Delmas A; Morinet F
Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
[TBL] [Abstract][Full Text] [Related]
29. Inactivation and neutralization of parvovirus B19 Genotype 3.
Blümel J; Rinckel LA; Lee DC; Roth NJ; Baylis SA
Transfusion; 2012 Jul; 52(7):1490-7. PubMed ID: 22339291
[TBL] [Abstract][Full Text] [Related]
30. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.
Schneider B; Becker M; Brackmann HH; Eis-Hübinger AM
Thromb Haemost; 2004 Oct; 92(4):838-45. PubMed ID: 15467916
[TBL] [Abstract][Full Text] [Related]
31. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products.
Saldanha J
J Clin Virol; 2001 Jan; 20(1-2):7-13. PubMed ID: 11163577
[TBL] [Abstract][Full Text] [Related]
32. Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies.
Slavov SN; Kashima S; Silva-Pinto AC; Covas DT
Can J Microbiol; 2012 Feb; 58(2):200-5. PubMed ID: 22280886
[TBL] [Abstract][Full Text] [Related]
33. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
34. Detection of hepatitis C virus and parvovirus B19 in human plasma pools by nucleic-acid amplification techniques - Trends in results of EDQM proficiency testing studies from 2004 to 2018.
Taconet L; Seifner A; Baylis SA; Chudy M; Kreβ J; Mathys E; Wirz M; Buchheit KH; Behr-Gross ME
Biologicals; 2021 Jun; 71():9-19. PubMed ID: 34006447
[TBL] [Abstract][Full Text] [Related]
35. Safety issues for plasma derivatives and benefit from NAT testing.
Willkommen H; Schmidt I; Löwer J
Biologicals; 1999 Dec; 27(4):325-31. PubMed ID: 10686059
[TBL] [Abstract][Full Text] [Related]
36. The detection of parvoviruses.
Doyle S
Methods Mol Biol; 2011; 665():213-31. PubMed ID: 21116804
[TBL] [Abstract][Full Text] [Related]
37. Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives.
Zhang W; Ke L; Changqing L; Zhang Y; Li W
J Transl Med; 2012 Sep; 10():194. PubMed ID: 22978673
[TBL] [Abstract][Full Text] [Related]
38. Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations.
Jain A; Kant R
Indian J Med Res; 2018 Mar; 147(3):239-247. PubMed ID: 29923512
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 1A complete genome from a fatal case in Brazil.
Conteville LC; Zanella L; Marín MA; Filippis AM; Nogueira RM; Vicente AC; Mendonça MC
Mem Inst Oswaldo Cruz; 2015 Sep; 110(6):820-1. PubMed ID: 26517666
[TBL] [Abstract][Full Text] [Related]
40. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
